Heading to San Francisco from January 13–16 for BIO Partnering, Biotech Showcase, Fierce Pharma, or RESI? Our experts, CEO Matthew Stober, CFO Thomas Castellano, and VPs of Business Development Zoe Yi Zhang and Sudha Krishnan, will be on-site to discuss the ways Abzena can advance your complex biologic or bioconjugate (ADC/AOC/RDC) programs.

Whether you need support with lead optimization, developability, analytical method development, process scale-up, cGMP manufacturing, or investor engagement, our experts can guide you toward a faster path to clinical and commercial success. Complete the form below to schedule a meeting and learn how Abzena’s integrated solutions can help accelerate your drug development journey.